Wait Times in Diagnostic Evaluation and Treatment for Patients With Stage III Non-Small Cell Lung Cancer in British Columbia
Authors:
- Elaine S. WaiEWElaine S. Wai
- Murray MackinnonMMMurray Mackinnon
- Ross HookerRHRoss Hooker
- Patrizia MocciaPMPatrizia Moccia
- Kristi R. PerryKPKristi R. Perry
- Pauline T. TruongPTPauline T. Truong
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 35 (4) , 373-377
Abstract
Non-small cell lung cancer (NSCLC) is associated with poor prognosis. Although this is mostly due to the aggressive natural history of the disease, the effect of treatment delays on patient outcomes is unclear. This study examines various time intervals in the diagnostic evaluation, staging, and treatment of patients with unresectable stage III NSCLC. A case-control study of patients with stage III NSCLC in British Columbia was carried out. One hundred nineteen patients treated radically with chemoradiotherapy were matched with 238 patients treated palliatively. Multivariate analysis was used to compare treatment delays and prognostic factors in the 2 groups. Compared with radically treated cases, patients treated palliatively had shorter median times from first symptom to first abnormal test (32 vs. 58 d) and from first symptom to pathologically confirmed diagnosis (67 vs. 90 d). More radically treated patients (61% vs. 50%) were first assessed by a thoracic surgeon, whereas more palliatively treated patients (73% vs. 50%) were initially assessed by a respirologist. The median time from diagnosis to referral to a cancer center was similar between the 2 groups, but palliative cases were 5 times more likely to have a delay of >55 days between diagnosis and referral. This delay was observed in 24% of palliatively treated and 7% of radically treated cases. The wait time from first symptom to referral to a regional cancer center in British Columbia for stage III NSCLC was approximately 3 to 4 months. Efforts to reduce wait times are warranted to reduce patient distress and possibly disease progression.Keywords
This publication has 29 references indexed in Scilit:
- Factors contributing to the time taken to consult with symptoms of lung cancer: a cross-sectional studyThorax, 2008
- Time to Treat: A System Redesign Focusing on Decreasing the Time from Suspicion of Lung Cancer to DiagnosisJournal of Thoracic Oncology, 2007
- Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast CancerJournal of Thoracic Oncology, 2007
- Screening for depressive symptoms in patients with unresectable lung cancerSupportive Care in Cancer, 2007
- Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosisThorax, 2005
- Time Course from First Symptom to the Treatment of Lung Cancer in the Eastern Black Sea Region of TurkeyMedical Principles and Practice, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Cancer patients consultation patterns in primary care and levels of psychological morbidity: Findings from the Health Survey for EnglandPsycho-Oncology, 2003
- Patient's and doctors’ delays in the diagnosis of chest tumorsLung Cancer, 2002
- Delays in the diagnosis and surgical treatment of lung cancer.Thorax, 1996